As of 2025-08-07, the EV/EBITDA ratio of Northeast Pharmaceutical Group Co Ltd (000597.SZ) is 23.02. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 000597.SZ's latest enterprise value is 11,626.89 mil CNY. 000597.SZ's TTM EBITDA according to its financial statements is 505.06 mil CNY. Dividing these 2 quantities gives us the above 000597.SZ EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 19.9x | 14.8x |
| Forward P/E multiples | 8.7x - 9.0x | 8.9x |
| Fair Price | 1.61 - 4.74 | 2.85 |
| Upside | -72.5% - -18.8% | -51.2% |
| Date | EV/EBITDA |
| 2025-08-05 | 23.73 |
| 2025-08-04 | 23.84 |
| 2025-08-01 | 24.07 |
| 2025-07-31 | 24.18 |
| 2025-07-30 | 24.21 |
| 2025-07-29 | 24.60 |
| 2025-07-28 | 24.69 |
| 2025-07-25 | 24.86 |
| 2025-07-24 | 24.29 |
| 2025-07-23 | 24.35 |
| 2025-07-22 | 23.67 |
| 2025-07-21 | 23.56 |
| 2025-07-18 | 22.23 |
| 2025-07-17 | 22.09 |
| 2025-07-16 | 21.95 |
| 2025-07-15 | 21.69 |
| 2025-07-14 | 21.98 |
| 2025-07-11 | 21.78 |
| 2025-07-10 | 21.64 |
| 2025-07-09 | 21.44 |
| 2025-07-08 | 21.61 |
| 2025-07-07 | 21.55 |
| 2025-07-04 | 21.61 |
| 2025-07-03 | 21.58 |
| 2025-07-02 | 21.35 |
| 2025-07-01 | 21.38 |
| 2025-06-30 | 21.10 |
| 2025-06-27 | 21.07 |
| 2025-06-26 | 21.07 |
| 2025-06-25 | 21.27 |
| 2025-06-24 | 21.30 |
| 2025-06-23 | 21.01 |
| 2025-06-20 | 21.13 |
| 2025-06-19 | 21.10 |
| 2025-06-18 | 21.35 |
| 2025-06-17 | 21.64 |
| 2025-06-16 | 21.64 |
| 2025-06-13 | 21.61 |
| 2025-06-12 | 21.78 |
| 2025-06-11 | 21.83 |
| 2025-06-10 | 21.95 |
| 2025-06-09 | 21.92 |
| 2025-06-06 | 21.69 |
| 2025-06-05 | 21.66 |
| 2025-06-04 | 21.86 |
| 2025-06-03 | 21.83 |
| 2025-05-30 | 21.44 |
| 2025-05-29 | 21.35 |
| 2025-05-28 | 21.07 |
| 2025-05-27 | 21.27 |